Taipei, Taiwan — The risk of dying of aspiration pneumonia among people with Alzheimer's disease and related dementias (ADRD) is higher for men than women and, in the United States, is higher for ...

"This finding suggests that it may be beneficial to reassess the preoperative withholding guidelines for GLP-1 RAs." HealthDay News — Preoperative glucagon-like peptide-1 receptor agonist (GLP-1 RA) ...

Poor nutritional status and increased severity of pneumonia were associated with higher mortality rates among patients with aspiration pneumonia, according to a recent study. “Aspiration pneumonia is ...

Aspiration pneumonia is a type of pneumonia caused by the accidental infiltration of food or other substances from the mouth or stomach into the lungs. The condition can be caused by bacteria that ...

European medical officials advised patients taking GLP-1 weight loss and diabetes drugs who will be sedated for an upcoming surgery to warn their doctors about their medication use to avoid the risk ...

A simple sip of water can turn life-threatening, leading to aspiration pneumonia when liquid enters the lungs instead of the stomach. This condition, often caused by bacteria in aspirated material, ...

The use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may lead to an increased risk for aspiration pneumonia after endoscopic procedures, according to a new large population-based study. In ...

The study was prompted by an increase in colonoscopies performed with propofol, a common ambulatory anesthesia drug. Researchers from Case Western Reserve University in Cleveland reviewed 5 percent of ...

On a follow-up visit to the pulmonologist, she is told that she had a severe case of community-acquired pneumonia (CAP), likely caused by her close work with children. However, the lack of positive ...

New research from Cedars-Sinai suggests people who are scheduled for certain medical procedures should stop taking popular weight loss drugs in the days or weeks prior to avoid complications.

Compared with 0.63% of non-users, 0.83% patients on a GLP-1 receptor agonist experienced aspiration pneumonia within a month of the procedure, Kevin Sheng-Kai Ma, DDS, of Brigham and Women's Hospital ...